Skip Content
You are currently on the new version of our website. Access the old version .
Journal: CancersVolume: 13Number: 805
Article: An Investigator-Initiated Phase 2 Study of Nivolumab Plus Low-Dose Ipilimumab as First-Line Therapy for Microsatellite Instability—High Advanced Gastric or Esophagogastric Junction Cancer (NO LIMIT, WJOG13320G/CA209-7W7)
  • Authors:
  • Hisato Kawakami1,*,
  • Shuichi Hironaka2 and
  • Kei Muro7
  • et al.
Link: https://www.mdpi.com/2072-6694/13/4/805

MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article and designed to be complimentary to the journal.

Order Cost and Details

Production Quality: High quality (printed in full color on glossy, 135g/m2 paper and 2x stitched)

Shipping Address

Billing Address

0 / 500
The order must be prepaid after it is placed.